BBI Life Sciences

BBI Life Sciences, established in 2013 and trading under the ticker HKEX: 1035, operates within the Office Products Retail & Distribution and Retail industries. The company is recognized as a key supplier of life science research products, catering to a broad market. Its strategic focus on science and life science research products positions it within a specialized segment of the scientific supply chain. The company's operational footprint is currently consolidated, with a reported location count of one, indicating a focused operational structure.

With an employee range of 1,000 - 5,000 employees, BBI Life Sciences demonstrates a significant operational capacity. Its description highlights its role as a well-recognized supplier, emphasizing its established presence and reputation in the life science research sector. The company's business model appears to encompass both B2C and potentially B2B aspects, as suggested by its industry classification and product offerings, serving diverse client needs.

Financially, BBI Life Sciences reported a revenue of $82.2M. The company has also secured funding, including a stock issuance/offering of $37.4M in February 2015, indicating investment in its growth and operations. Further details on its financial performance and market standing can be found by accessing Explore financial highlights. The company's fiscal year concludes on December 31st, with public reporting occurring in Q3 and Q4 of 2019, providing timely market insights.